Impaired Set-Shifting Ability in Patients with Eating Disorders, Which Is Not Moderated by Their Catechol-O-Methyltransferase Val158Met Genotype by Kim, Youl-Ri et al.
Print ISSN 1738-3684 / On-line ISSN 1976-3026
OPEN ACCESS DOI 10.4306/pi.2010.7.4.298
298  Copyright © 2010 Korean Neuropsychiatric Association  
BRIEF REPORT
Impaired Set-Shifting Ability in Patients with Eating Disorders, 
Which Is Not Moderated by Their Catechol-O-Methyltransferase 
Val158Met Genotype
Youl-Ri Kim, Ji Eun Kim and Mi Hyun Kim
Department of Neuropsychiatry, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea
The aim of this study was to examine the set-shifting ability in women with both anorexia nervosa (AN) and bulimia nervosa (BN) and 
to investigate whether it is contributed by the catechol-O-methyltransferase (COMT) Val158Met genotype. A total of 102 Korean partic-
ipants-40 women with lifetime AN, 28 women with lifetime BN, and 34 healthy women of comparable age and intelligence quotient-
were examined. A neuropsychological battery of tests was applied and blood samples were obtained for COMT Val158Met genotyping. 
Set-shifting impairments Trail Making Test (TMT, Part B) were found in patients with AN and BN, respectively. Furthermore, the eating 
disorders were also linked to deficits in attentional mechanisms (TMT, Part A) and motor skills (Finger Tapping Test). Finally, set-shift-
ing and its link to eating disorders were not moderated by COMT Val158Met genotype.  Psychiatry Investig 2010;7:298-301
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INTRODUCTION
Eating disorders aggregate in family,
1 and the variance in 
heredity lies between 33% and 84% in twin studies.
2 Using en-
dophenotypic markers may have great potential for finding 
the candidate genes, as they are generally less complex than 
their associated phenotype and, thus, may be more readily li-
nked to a specific genetic locus.
3 It has been suggested that the 
cognitive behavioral inflexibility observed in patients with 
eating disorders is linked to their set-shifting problem.
4 The set-
shifting ability is considered as a candidate endophenotype of 
anorexia nervosa (AN),
5 because pairs of sisters one of whom 
has AN as well as women with AN, tend to have delayed set-
shifting.
6 Whereas there is accumulating evidence for im-
paired set-shifting ability in AN, much remains unknown with 
respect to bulimia nervosa (BN).
7 The catechol-O-methyltr-
ansferase (COMT) gene is one of the candidate genes for im-
paired cognitive flexibility. The COMT Val158Met functional 
polymorphism appears to selectively impact prefrontal dopa-
mine regulation and this gene has been shown to predict per-
formance on prefrontal executive cognition and working me-
mory tasks in healthy individuals.
8 
In the present study, we hypothesized that individuals with 
BN as well as AN would show impaired set-shifting ability. An 
extensive review of the previous literature guided our choice 
of the Trail Making Test (TMT)
9 as the measure to use for the 
set-shifting ability, as it is the most commonly employed set-
shifting measure with the acceptable and consistent effect size.
7 
We also attempted to investigate whether their set-shifting 
ability is affected by the COMT Val158Met genotype. To the 
best of our knowledge, this is the first study to examine the pos-
sible association between endophenotypes and liable genes 
in eating disorders.
METHODS
A total of 102 women, comprising 40 patients with AN and 
28 patients with BN, as well as 34 healthy controls, participat-
ed in this study. The diagnosis of lifetime AN or BN was made 
using the Eating Disorders Examination Questionnaire Ver-
sion (EDE-Q)
10 on the basis of the hierarchical model of diag-
nosis used in a genetic study.
11 Neuropsychological tests were ap-YR Kim et al. 
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plied to all participants and their blood samples were collected 
for the COMT Val158Met genotyping. The exclusion criteria 
for all participants were a history of neurologic illness, brain in-
jury, substance-abuse disorders, or psychosis in the past. Only 
the use of selective serotonin reuptake inhibitors (SSRIs) was 
permitted within 2 weeks before the neuropsychological test. 
Nineteen (48%) of AN and fifteen (54%) of BN were taking 
SSRIs at the time of the study. The Korean version of the We-
chsler Adult Intelligent Scale was administered to match the 
groups in terms of their general intelligence.
12 The patients un-
derwent an interview for measuring their symptoms of eat-
ing disorders by using the Korean version of the 12th edition 
of the EDE.
13 Their comorbid clinical symptoms were mea-
sured by the Korean versions of the Beck Depression Inven-
tory (BDI),
14 the Spielberger State and Trait Anxiety Invento-
ry,
15 and the Maudsley Obsessive Compulsive Inventory,
16 res-
pectively. The participants completed various computerized 
neuropsychological tests spanning the cognitive domains of 
the TMT Part B for set-shifting ability, the Visual Span Test (VST; 
Corsi block tapping test)
17 for visual/working memory, the TMT 
Part A
9 for attention, and the Finger Tapping Test (FTT)
18 for 
motor function. A meta-analysis revealed no evidence of pub-
lication bias for the TMT Part B
7 and, therefore, the uncorrect-
ed data is presented in this study. According to Korean norma-
tive data, the test/retest reliability coefficients of the computeriz-
ed tests were acceptable.
19,20 Deoxyribonucleic acid (DNA) was 
extracted from blood leukocytes by using a commercial DNA 
extraction kit (ABI, Foster City, CA, USA). Genotyping of the 
COMT Val158Met variant was carried out with a polymerase 
chain reaction (PCR)-based restriction fragment length poly-
morphism analysis by using the primers 5’-CTCATCACCA 
TCGAGATCAA-3’ and 5’-CCAGGTCTGAAACGGGTCA-3’. 
The PCR products digested with NlaIII were electrophoresed 
to distinguish between the Val and Met alleles. This study was 
approved by the Institutional Review Board of Seoul Paik Hos-
pital in Seoul, Korea. Written informed consent was obtained 
from all of the participants.
Group differences in the neuropsychological tests were test-
ed in a one-way analysis of covariance with the years of educa-
tion included as a covariate, since the AN group had a short-
er educational years than the other groups (AN: 12.70±3.38 
years, BN: 13.57±2.20 years, controls: 14.65±1.87 years; F= 
4.99, df=2/99, p=0.009). For the set-shifting ability, a multi-
variate analysis of variance (MANOVA) in the groups was com-
puted by integrating the two scores of the TMT Part B (total 
errors, time taken). The MANCOVAs were repeated using 
the general psychiatric measures as covariates to investigate the 
contribution of general psychiatric symptoms on the perfor-
mance on the neuropsychological tests. We carried out the 
subsidiary analysis to test the effect of medication on the per-
formance of the neuropsychological tests with a comparison 
of the patients in the medicated subgroup with those in the 
non-medicated subgroup. For effect of the COMT genotype 
on the set-shifting ability, a two way MANOVA for integrating 
the time taken and total errors of the TMT Part B was comput-
ed with the two factors, genotype and group. Two-tailed tests 
were used and a p-value <0.05 was considered to be indicative 
of statistical significance.
RESULTS
The clinical characteristics, the frequency of genotypes for 
the COMT Val158Met, and the performance on the neuropsy-
chological tests of the participants are shown in Table 1. Both 
the AN and BN groups showed significantly poorer perform-
ance on the TMT Part A and FTT than the controls, but not on 
the VST. The MANOVA showed a significant effect of diagno-
sis on the set-shifting ability with Pillai’s F=4.48, df=4/196, p= 
0.002 on the TMT Part B. Depression was slightly associated 
with the performance on the set-shifting task (F=3.38, df=2/93, 
p=0.038), but the effect of the group were also significant for 
the score of BDI as a covariate (F=3.36, df=4/188, p=0.011). 
There was no evidence that anxiety, obsessive-compulsiveness, 
or symptoms of eating disorders was associated with the set-
shifting ability. In a subsidiary analysis, the results revealed no 
significant group differences across all neuropsychological tasks 
in comparisons of the women with eating disorders who were 
or were not currently receiving antidepressants. We could not 
find any main effect of the COMT Val158 Met genotype (F= 
0.54, df=4/184, p=0.703), group (F=2.41, df=4/184, p=0.051), 
or any interaction effects between the genotype and group (F= 
0.50, df=8/184, p=0.858) on the performance of the set-shift-
ing ability. 
DISCUSSION
In this study, we reported set-shifting impairments were 
found in patients with AN and BN, respectively. Furthermore, 
the eating disorders were also linked to deficits in attentional 
mechanisms and motor skills. This study furthers our under-
standing of the possibility of set-shifting deficit being used as 
an endophenotype of BN as well as AN.
These neuropsychological data are consistent with previ-
ous evidence of there being an impairment in attention and mo-
tor skill in underweight and recovered AN and BN patients, 
but no differences in the working memory or speed of mem-
ory.
21 Although the performance on the set-shifting task was 
related to depression, the set-shifting deficit still remained af-
ter controlling for the effect of depression, indicating the def-
icit is a feature independent of the comorbidities. 300  Psychiatry Investig 2010;7:298-301
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In our study, the COMT Val158Met genotype was not in-
volved in the impaired set-shifting ability in both AN and BN. 
Despite this finding, there is no doubt that genetic variants are 
associated with the endophenotype (viz. set-shifting deficit). 
It may be more useful to use of the endophenotypic marker 
for uncovering genetic commonalities across psychiatric dis-
orders than for a single disorder (viz. eating disorder) as set-
shifting appears to broadly increase the risk of many forms of 
psychiatric illness.
22-24 The limitations of the study were to use 
of the TMT Part B solely as a measure of the set-shifting abil-
ity, and the relatively small sample size, which may reduce its 
power to detect an association. Furthermore, the multiple test-
ings to examine links between the set-shifting deficit and pos-
sible genetic markers might increase the probability of type 1 
errors. 
In conclusion, our findings suggest that impaired set-shift-
Table 1. The clinical characteristics, genotypes, and performance of neuropsychological tasks of the participants
Variables
AN 
(A; N=40)
BN 
(B; N=28)
HC 
(C; N=34)
Analysis
Statistics (df) p
Clinical characteristics
Age (years) 22.78±7.23 23.00±3.21 22.65±3.57 F (2,99)=0.04 0.966
Age of onset (years) 18.55±4.59 20.07±2.99 N/A t (65)=1.52 0.133
Current BMI (kg/m
2) 16.67±2.60 20.66±2.65 21.52±1.680 F (2,99)=44.96 <0.001
Lowest ever BMI (kg/m
2) 14.60±1.51 08.12±2.19 20.19±1.520 F (2,99)=99.25 <0.001
WAIS-IQ 108.50±9.610 108.75±11.85 107.53±9.07 00 F (2,99)=1.33 0.876
BDI 019.87±13.60 018.64±11.91 5.82±5.95 F (2,99)=16.84 <0.001
STAI 106.58±25.65 110.52±25.20 81.76±22.74 F (2,99)=12.73 <0.001
K-MOCI 39.40±6.09 38.24±5.16 35.88±4.110 F (2,99)=4.08 0.020
EDE, global 061.26±21.99 078.21±21.99 N/A t (65)=3.11 0.003
COMT Val158Met genotype 
Val/Val 22 (55%) 14 (50%) 16 (47%)
A vs C : χ2 (2)=1.27, p=0.53
B vs C : χ2 (2)=0.69, p=0.71
Val/Met 14 (35%) 11 (39%) 16 (47%)
Met/Met 04 (10%) 03 (11%) 02 (6%)
Set-shifting ability
    Trail Making Test, Part B
Time 039.28±12.22 00049.54±33.24** 31.35±7.990 6.45 0.002
Errors 0005.86±8.79** 00006.43±10.05** 0.82±1.49 5.23 0.007
Attention
    Trail Making Test, Part A
Time 0025.95±8.88** 0024.46±7.21** 19.41±4.460 7.25 0.001
Errors 004.33±7.26* 004.64±8.16* 0.82±1.06 3.47 0.035
Visual/Working memory
    Visual Span Test
Forward 06.33±0.96 06.76±1.17 6.29±0.91 1.97 0.144
Backward 05.43±0.89 05.55±0.94 5.72±0.66 1.62 0.204
Motor skill
    Finger Tapping Test
Right, taps 0053.91±8.40** 056.30±5.91* 61.50±6.010 7.45 0.001
Left, taps   048.61±6.41* 0048.18±9.63** 54.83±4.820 7.00 0.001
Data are shown as mean±SD or number (percentage) as appropriate. The differences in the genotype frequencies between the patients (AN, 
BN) and the healthy controls were evaluated using a χ2 test. Analysis by ANCOVA for neuropsychological tasks as covariate of years of educa-
tion. *p<0.05, **p<0.01 compared on cognitive performance as contrasted with controls. N/A: no normative data given, AN: anorexia nervosa, 
BN: bulimia nervosa, HC: healthy controls, BMI: Body Mass Index, K-WAIS: Korean-Wechsler Adult Intelligent Scale, BDI: Beck Depression 
Inventory, STAI: State and Trait Anxiety Inventory, K-MOCI: Korean version of Maudsley Obsessive and Compulsive Inventory, EDE: Eating 
Disorders Examination Interview  YR Kim et al. 
   www.psychiatryinvestigation.org  301
ing ability is a common feature for both AN and BN patients 
and its link to eating disorders were not moderated by the CO-
MT Val158Met genotype.
Acknowledgments
This work was supported by a Korea Research Foundation Grant funded 
by the Korean Government (MOEHRD) (KRF-2006-331-E00203).
REFERENCES
1. Strober M, Freeman R, Lampert C, Diamond J, Kaye W. Controlled fam-
ily study of anorexia nervosa and bulimia nervosa: evidence of shared 
liability and transmission of partial syndromes. Am J Psychiatry 2000; 
157:393-401.
2. Bulik CM. Exploring the gene-environment nexus in eating disorders. 
J Psychiatry Neurosci 2005;30:335-339.
3. Glahn DC, Bearden CE, Niendam TA, Escamilla MA. The feasibility of 
neuropsychological endophenotypes in the search for genes associated 
with bipolar affective disorder. Bipolar Disord 2004;6:171-182.
4. Tchanturia K, Anderluh MB, Morris RG, Rabe-Hesketh S, Collier DA, 
Sanchez P, et al. Cognitive flexibility in anorexia nervosa and bulimia 
nervosa. J Int Neuropsychol Soc 2004;10:513-520.
5. Bulik CM, Hebebrand J, Keski-Rahkonen A, Klump KL, Reichborn-
Kjennerud T, Mazzeo SE, et al. Genetic epidemiology, endophenotypes, 
and eating disorder classification. Int J Eat Disord 2007;40:S52-S60.
6. Holliday J, Tchanturia K, Landau S, Collier D, Treasure J. Is impaired set-
shifting an endophenotype of anorexia nervosa? Am J Psychiatry 2005; 
162:2269-2275.
7. Roberts ME, Tchanturia K, Stahl D, Southgate L, Treasure J. A systemat-
ic review and meta-analysis of set-shifting ability in eating disorders. Psy-
chol Med 2007;37:1075-1084.
8. Barnett JH, Jones PB, Robbins TW, Müller U. Effects of the catechol-
O-methyltransferase Val158Met polymorphism on executive function: 
a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and 
healthy controls. Mol Psychiatry 2007;12:502-509.
9. Reitan RM. Validity of the trail making test as indicator of organic brain 
damage. Percept Mot Skills 1958;8:271-276.
10. Fairburn CG, Beglin SJ. Assessment of eating disorders-interview or self-
report questionnaire? Int J Eat Disord 1994;16:363-370.
11.   Kaye WH, Lilenfeld LR, Berrettini WH, Strober M, Devlin B, Klump 
KL, et al. A search for susceptibility loci for anorexia nervosa: methods 
and sample description. Biol Psychiatry 2000;47:794-803.
12. Yum TH, Park YS, Oh KJ, Kim JG, Lee HY. The manual of Korean-
Wechsler adult intelligence scale. Seoul: Korean Guidance Press; 1992.
13. Heo SY, Rhee MK, Choi YM, Sohn CH, Lee HK, Lee YH. Reliability and 
factor analysis of the Korean version of eating disorder examination. J 
Korean Soc Study Obes 2004;13:42-52.
14. Han HM, Yeom TH, Shin YW. The validity and reliability of Beck de-
pression inventory Korean version. J Korean Neuropsychiatr Assoc 
1986;25:487-500.
15. Kim JT, Shin DK. A study based on the standardization of the state and 
trait anxiety inventory for Korea. New Med J 1978;21:69-75.
16. Min BB, Won HT. Reliability and validity of the Korean translations of 
Maudsley obsessional-compulsive inventory and Padua inventory. Ko-
rean J Clin Psychol 1999;18:163-182. 
17.   Corsi PM. Human memory and the medial temporal region of the brain: 
Dissertation Abstracts International, 34(02), 891B (University Micro-
films No. AA105-77717). 1972.
18. Spreen O, Strauss E. A compendium of neuropsychological tests. 2nd edi-
tion. New York: Oxford University Press; 1998.
19. Ha KS, Kwon JS, Lyoo IK. Development and standardization of the com-
puterized attention assessment for Korean adults. J Korean Neuropsy-
chiatr Assoc 2002;41:335-346.
20. Kwon JS, Lyoo IK, Hong KS, Yeon BK, Ha KS. Development and standar-
dization of the computerized memory assessment for Korean adults. J 
Korean Neuropsychiatr Assoc 2002;41:347-362.
21. Bosanac P, Kurlender S, Stojanovska L, Hallam K, Norman T, McGrath 
C, et al. Neuropsychological study of underweight and “weight-recov-
ered” anorexia nervosa compared with bulimia nervosa and normal con-
trols. Int J Eat Disord 2007;40:613-621.
22. Snitz BE, Macdonald AW 3rd, Carter CS. Cognitive deficits in unaffect-
ed first degree relatives of schizophrenia patients: a meta-analytic review 
of putative endophenotypes. Schizophr Bull 2006;32:179-194.
23.   Clark L, Sarna A, Goodwin GM. Impairment of executive function but 
not memory in first-degree relatives of patients with bipolar I disorder 
and in euthymic patients with unipolar depression. Am J Psychiatry 2005; 
162:1980-1982.
24.   Treasure JL. Getting beneath the phenotype of anorexia nervosa: the 
search for viable endophenotypes and genotypes. Can J Psychiatry 2007; 
52:212-219.